Altamira Therapeutics Ltd (CYTO)
1.78
+0.07
(+4.09%)
USD |
NASDAQ |
May 24, 16:00
1.80
+0.02
(+1.12%)
After-Hours: 20:00
Altamira Therapeutics Total Liabilities (Quarterly): 1.471M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.471M |
| June 30, 2023 | 8.928M |
| June 30, 2023 | 8.928M |
| December 31, 2022 | 15.77M |
| June 30, 2022 | 11.32M |
| June 30, 2022 | 11.32M |
| December 31, 2021 | 6.710M |
| June 30, 2021 | 3.961M |
| June 30, 2021 | 3.961M |
| December 31, 2020 | 4.612M |
| June 30, 2020 | 3.664M |
| June 30, 2020 | 3.664M |
| December 31, 2019 | 3.292M |
| June 30, 2019 | 2.847M |
| December 31, 2018 | 6.325M |
| September 30, 2018 | 8.960M |
| June 30, 2018 | 11.04M |
| March 31, 2018 | 18.04M |
| Date | Value |
|---|---|
| December 31, 2017 | 20.52M |
| September 30, 2017 | 24.11M |
| June 30, 2017 | 24.83M |
| March 31, 2017 | 26.50M |
| December 31, 2016 | 21.14M |
| September 30, 2016 | 22.42M |
| June 30, 2016 | 8.982M |
| March 31, 2016 | 8.294M |
| December 31, 2015 | 8.165M |
| September 30, 2015 | 8.289M |
| June 30, 2015 | 8.819M |
| March 31, 2015 | 7.189M |
| December 31, 2014 | 6.280M |
| September 30, 2014 | 7.055M |
| June 30, 2014 | 4.199M |
| March 31, 2014 | 4.493M |
| December 31, 2013 | -14.40M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.471M
Minimum
Dec 2023
15.77M
Maximum
Dec 2022
6.461M
Average
4.287M
Median
Total Liabilities (Quarterly) Benchmarks
| Kiniksa Pharmaceuticals Ltd | 87.78M |
| Tiziana Life Sciences Ltd | 6.648M |
| Landos Biopharma Inc | 6.742M |
| AbbVie Inc | 140.83B |
| Masimo Corp | 1.592B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.160M |
| Shareholders Equity (Quarterly) | 7.690M |
| Current Ratio | 1.376 |
| Net Debt Paydown Yield | 31.93% |